AAPL Apple | Target Set by | Wedbush Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating | | $256.08 +4.3% | $270.00 ➝ $310.00 | Outperform | |
ABBV AbbVie | Target Raised by | Evercore ISI Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating | | $223.09 +0.3% | $207.00 ➝ $222.00 | Outperform | |
AGX Argan | Initiated by | Glj Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating | | $268.99 +3.2% | $251.00 | Hold | |
AII American Integrity Insurance Group | Reiterated by | Raymond James Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating | | $22.48 +4.5% | $22.00 ➝ $24.00 | Outperform | |
ALB Albemarle | Target Raised by | HSBC Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating | | $80.45 -1.7% | $60.00 ➝ $75.00 | Hold | |
AMAT Applied Materials | Upgraded by | Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating | | $200.52 +5.5% | $172.00 ➝ $209.00 | Equal Weight ➝ Overweight | |
AMCR Amcor | Initiated by | Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating | | $8.27 +0.1% | | Sector Perform | |
ANIX Anixa Biosciences | Reiterated by | D. Boral Capital Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating | | $3.49 +5.8% | $10.00 | Buy | |
AS Amer Sports | Target Set by | Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating | | $35.36 -5.6% | $41.00 | Positive | |
AS Amer Sports | Target Raised by | Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating | | $35.36 -5.6% | $35.00 ➝ $38.00 | Equal Weight | |
Get the Latest News and Ratings for Your Stocks Enter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter.
|
ASML ASML | Upgraded by | Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating | | $957.80 +2.8% | | Equal Weight ➝ Overweight | |
ASML ASML | Upgraded by | Erste Group Bank Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating | | $957.80 +2.8% | | Hold ➝ Buy | |
ATOS Atossa Genetics | Target Raised by | Ascendiant Capital Markets Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating | | $0.83 -2.1% | $7.50 ➝ $7.75 | Buy | |
AUGO Aura Minerals | Initiated by | Bank of America Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating | | $34.38 +7.5% | $40.00 | Buy | |
AVPT AvePoint | Target Set by | DA Davidson Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating | | $15.75 +0.5% | $20.00 | | |
B Barrick Mining | Target Set by | Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating | | $35.37 +7.2% | $38.00 | Outperform | |
B Barrick Mining | Reiterated by | CIBC Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating | | $35.37 +7.2% | | Outperform | |
B Barrick Mining | Upgraded by | National Bankshares Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating | | $35.37 +7.2% | | Outperform | |
B Barrick Mining | Reiterated by | BMO Capital Markets Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating | | $35.37 +7.2% | | Market Perform | |
B Barrick Mining | Target Raised by | CIBC Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating | | $35.37 +7.2% | $30.00 ➝ $38.00 | Outperformer | |
B Barrick Mining | Upgraded by | National Bank Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating | | $35.37 +7.2% | | Sector Perform ➝ Outperform | |
B Barrick Mining | Target Raised by | Raymond James Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating | | $35.37 +7.2% | $32.00 ➝ $36.00 | Outperform | |
B Barrick Mining | Target Raised by | TD Securities Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating | | $35.37 +7.2% | $30.00 ➝ $38.00 | Buy | |
BB BlackBerry | Target Set by | Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating | | $4.41 +4.6% | $4.00 | Sector Perform | |
BBNX Beta Bionics | Target Raised by | Truist Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating | | $22.90 +2.0% | $21.00 ➝ $28.00 | Buy | |
BIDU Baidu | Target Raised by | Nomura Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating | | $136.63 +0.9% | $91.00 ➝ $135.00 | Neutral | |
BNTX BioNTech | Target Raised by | JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating | | $98.72 +2.6% | $116.00 ➝ $121.00 | Neutral | |
BPOP Popular | Target Raised by | Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating | | $126.98 -0.8% | $140.00 ➝ $150.00 | Overweight | |
BTDR Bitdeer Technologies Group | Target Raised by | Roth Capital Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating | | $17.96 +9.2% | $18.00 ➝ $40.00 | Buy | |
BZ KANZHUN | Reiterated by | The Goldman Sachs Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating | | $23.76 -2.1% | | Buy | |
CAT Caterpillar | Target Raised by | Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating | | $471.97 +1.2% | $500.00 ➝ $540.00 | | |
CCCC C4 Therapeutics | Reiterated by | Stephens Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating | | $2.61 -17.4% | $6.00 | Overweight | |
CCCC C4 Therapeutics | Reiterated by | Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating | | $2.61 -17.4% | $10.00 | Overweight | |
CCI Crown Castle | Upgraded by | Wolfe Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating | | $94.19 +0.6% | $114.00 | Peer Perform ➝ Outperform | |
CDTX Cidara Therapeutics | Reiterated by | WBB Securities Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating | | $75.47 +9.8% | | Strong-Buy | |
CDTX Cidara Therapeutics | Target Raised by | WBB Securities Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating | | $75.47 +9.8% | $45.00 ➝ $123.00 | Strong-Buy | |
CELC Celcuity | Initiated by | Guggenheim Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating | | $52.49 +1.2% | | Buy | |
CLW Clearwater Paper | Initiated by | Cowen Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating | | $22.62 +7.5% | | Buy | |
CLW Clearwater Paper | Target Set by | TD Securities Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating | | $22.62 +7.5% | $30.00 | Buy | |
CLW Clearwater Paper | Initiated by | TD Cowen Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating | | $22.62 +7.5% | $30.00 | Buy | |
|
CLYM Climb Bio | Reiterated by | BTIG Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating | | $2.32 +0.4% | $7.00 | Buy | |
CMCSA Comcast | Target Lowered by | Loop Capital Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating | | $31.49 -0.3% | $50.00 ➝ $44.00 | Buy | |
COP ConocoPhillips | Target Raised by | BMO Capital Markets Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating | | $92.11 +0.2% | $113.00 ➝ $115.00 | Outperform | |
CRC California Resources | Target Raised by | Bank of America Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating | | $54.72 -0.5% | $60.00 ➝ $66.00 | Buy | |
CROX Crocs | Downgraded by | Piper Sandler Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating | | $77.14 -4.0% | $95.00 ➝ $75.00 | Overweight ➝ Neutral | |
CRWD CrowdStrike | Target Raised by | Canaccord Genuity Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating | | $493.14 -1.9% | $430.00 ➝ $500.00 | Hold | |
CSAN Cosan | Reiterated by | HSBC Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating | | $4.63 -18.3% | $4.40 | Hold ➝ Reduce | |
CSL Carlisle Companies | Target Lowered by | Truist Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating | | $337.69 -0.1% | $380.00 ➝ $350.00 | Hold | |
CTMX CytomX Therapeutics | Initiated by | Cantor Fitzgerald Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating | | $2.06 +4.0% | $6.00 | Overweight | |
CTMX CytomX Therapeutics | Upgraded by | Cantor Fitzgerald Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating | | $2.06 +4.0% | | Strong-Buy | |
CVS CVS Health | Target Raised by | Wolfe Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating | | $75.28 +0.5% | $80.00 ➝ $85.00 | Outperform | |
CYTK Cytokinetics | Reiterated by | HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating | | $48.25 -0.8% | $120.00 | Buy | |
CYTK Cytokinetics | Target Raised by | B. Riley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating | | $48.25 -0.8% | $74.00 ➝ $80.00 | Buy | |
DD DuPont de Nemours | Target Raised by | KeyCorp Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating | | $78.33 +0.3% | $92.00 ➝ $93.00 | Overweight | |
DHR Danaher | Target Lowered by | Bank of America Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating | | $190.30 -1.5% | $230.00 ➝ $220.00 | Buy | |
EAT Brinker International | Upgraded by | Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating | | $138.52 +1.6% | $165.00 ➝ $175.00 | Equal Weight ➝ Overweight | |
EG Everest Group | Downgraded by | Raymond James Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating | | $335.59 +0.1% | | Strong-Buy ➝ Moderate Buy | |
EG Everest Group | Target Set by | Raymond James Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating | | $335.59 +0.1% | $410.00 ➝ $375.00 | Strong-Buy ➝ Outperform | |
EQT EQT | Target Lowered by | BMO Capital Markets Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating | | $49.89 +1.4% | $62.00 ➝ $60.00 | Outperform | |
EVTL Vertical Aerospace | Reiterated by | Canaccord Genuity Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating | | $6.29 +9.7% | $11.00 | Buy | |
EW Edwards Lifesciences | Target Set by | Stifel Nicolaus Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating | | $73.80 -0.8% | $95.00 ➝ $85.00 | Buy | |
FDS FactSet Research Systems | Upgraded by | UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating | | $295.52 +2.2% | $480.00 ➝ $425.00 | Neutral ➝ Buy | |
FDX FedEx | Target Raised by | Sanford C. Bernstein Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating | | $230.40 -0.6% | $247.00 ➝ $250.00 | Market Perform | |
FDX FedEx | Target Raised by | Daiwa Capital Markets Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating | | $230.40 -0.6% | $232.00 ➝ $240.00 | Neutral | |
FLYW Flywire | Reiterated by | Stephens Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating | | $13.14 +0.2% | $13.00 | Equal Weight | |
FVR FrontView REIT | Target Raised by | JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating | | $13.56 -1.5% | $12.00 ➝ $15.00 | Neutral | |
GATX GATX | Upgraded by | Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating | | $176.41 +2.5% | | Strong-Buy | |
GATX GATX | Initiated by | Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating | | $176.41 +2.5% | $201.00 | Buy | |
GDYN Grid Dynamics | Initiated by | Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating | | $8.11 +7.7% | $11.00 | Buy | |
GDYN Grid Dynamics | Upgraded by | Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating | | $8.11 +7.7% | | Strong-Buy | |
GE GE Aerospace | Target Raised by | Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating | | $300.91 -0.1% | $320.00 ➝ $350.00 | Buy | |
GFR Greenfire Resources | Downgraded by | BMO Capital Markets Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating | | $4.88 -3.0% | | Outperform ➝ Market Perform | |
GH Guardant Health | Reiterated by | BTIG Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating | | $59.78 +1.1% | $70.00 | Buy | |
GH Guardant Health | Upgraded by | Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating | | $59.78 +1.1% | | Strong-Buy | |
GH Guardant Health | Initiated by | Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating | | $59.78 +1.1% | $72.00 | Overweight | |
GKOS Glaukos | Target Lowered by | Truist Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating | | $84.74 +1.5% | $126.00 ➝ $120.00 | Buy | |
GM General Motors | Target Raised by | Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating | | $58.94 -0.1% | $61.00 ➝ $75.00 | Buy | |
GOOG Alphabet | Target Raised by | Robert W. Baird Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating | | $252.88 -0.9% | $215.00 ➝ $275.00 | Outperform | |
GOOGL Alphabet | Target Raised by | Truist Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating | | $252.53 -0.9% | $225.00 ➝ $285.00 | Buy | |
GOOGL Alphabet | Target Raised by | Robert W. Baird Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating | | $252.53 -0.9% | $215.00 ➝ $275.00 | Outperform | |
HALO Halozyme Therapeutics | Target Raised by | HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating | | $78.28 +0.6% | $75.00 ➝ $85.00 | Buy | |
HCM HUTCHMED | Downgraded by | Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating | | $16.66 -2.2% | $18.00 ➝ $13.75 | Equal Weight ➝ Underweight | |
HGTY Hagerty | Initiated by | BMO Capital Markets Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating | | $12.25 -3.7% | $13.00 | Market Perform | |
HGTY Hagerty | Upgraded by | BMO Capital Markets Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating | | $12.25 -3.7% | | Hold | |
HOUS Anywhere Real Estate | Upgraded by | JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating | | $10.30 +45.7% | $10.00 | Underweight ➝ Neutral | |
HP Helmerich & Payne | Upgraded by | Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating | | $21.27 +3.6% | | Hold ➝ Strong-Buy | |
HP Helmerich & Payne | Target Set by | Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating | | $21.27 +3.6% | $17.00 ➝ $25.00 | Equal Weight ➝ Overweight | |
HSAI Hesai Group | Target Raised by | The Goldman Sachs Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating | | $29.71 +2.3% | $26.30 ➝ $36.00 | Buy | |
HSBC HSBC | Reiterated by | Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating | | $70.02 +0.4% | | Buy | |
HST Host Hotels & Resorts | Target Raised by | UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating | | $17.17 -1.4% | $17.00 ➝ $18.00 | Neutral | |
|
HTFL Heartflow | Target Raised by | Canaccord Genuity Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating | | $31.43 -4.4% | $35.00 ➝ $39.00 | Buy | |
HUM Humana | Initiated by | Evercore ISI Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating | | $258.09 +2.1% | $295.00 | In-Line | |
IDCC InterDigital | Reiterated by | William Blair Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating | | $346.49 +3.5% | | Outperform | |
IFF International Flavors & Fragrances | Target Lowered by | Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating | | $62.21 -2.1% | $92.00 ➝ $90.00 | Overweight | |
IMAX IMAX | Target Raised by | Wedbush Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating | | $32.64 +2.1% | $35.00 ➝ $39.00 | Outperform | |
IMNM Immunome | Upgraded by | The Goldman Sachs Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating | | $9.77 +4.0% | | Strong-Buy | |
IMNM Immunome | Initiated by | The Goldman Sachs Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating | | $9.77 +4.0% | $26.00 | Buy | |
INCY Incyte | Target Raised by | Stifel Nicolaus Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating | | $84.73 -2.1% | $110.00 ➝ $115.00 | Buy | |
INFU InfuSystem | Initiated by | Lake Street Capital Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating | | $10.41 +4.1% | $15.00 | Buy | |
INSP Inspire Medical Systems | Downgraded by | UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating | | $78.96 -1.2% | | Strong-Buy ➝ Hold | |
INSP Inspire Medical Systems | Target Set by | UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating | | $78.96 -1.2% | $230.00 ➝ $89.00 | Buy ➝ Neutral | |
INTC Intel | Upgraded by | Erste Group Bank Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating | | $28.76 -2.8% | | Sell ➝ Hold | |
IONQ IonQ | Target Raised by | B. Riley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating | | $71.90 +2.1% | $75.00 ➝ $100.00 | Buy | |
IONS Ionis Pharmaceuticals | Target Set by | Raymond James Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating | | $61.36 +0.6% | $75.00 | Strong-Buy | |
IRM Iron Mountain | Upgraded by | Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating | | $104.42 +4.5% | | Strong-Buy | |
IRM Iron Mountain | Initiated by | Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating | | $104.42 +4.5% | $120.00 | Buy | |
JBSS John B. Sanfilippo & Son | Initiated by | BWS Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating | | $64.25 +1.6% | $109.00 | Buy | |
JSPR Jasper Therapeutics | Target Lowered by | Evercore ISI Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating | | $2.54 +1.4% | $20.00 ➝ $14.00 | Outperform | |
JSPR Jasper Therapeutics | Target Lowered by | BTIG Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating | | $2.54 +1.4% | $20.00 ➝ $7.00 | Buy | |
JSPR Jasper Therapeutics | Target Lowered by | JMP Securities Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating | | $2.54 +1.4% | $12.00 ➝ $6.00 | Market Outperform | |
KDP Keurig Dr Pepper | Downgraded by | BNP Paribas Exane Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating | | $25.95 -4.3% | | Neutral ➝ Underperform | |
KDP Keurig Dr Pepper | Downgraded by | BNP Paribas Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating | | $25.95 -4.3% | | Neutral ➝ Underperform | |
KEX Kirby | Initiated by | Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating | | $85.85 +2.1% | $91.00 | Neutral | |
KEX Kirby | Upgraded by | Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating | | $85.85 +2.1% | | Hold | |
KLAC KLA | Target Set by | Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating | | $1,071.25 +2.5% | $928.00 ➝ $1,093.00 | Overweight ➝ Equal Weight | |
KMB Kimberly-Clark | Target Lowered by | Evercore ISI Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating | | $124.07 -0.4% | $155.00 ➝ $150.00 | Outperform | |
KOD Kodiak Sciences | Initiated by | Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating | | $15.01 +57.5% | $15.00 | Buy | |
KOS Kosmos Energy | Reiterated by | The Goldman Sachs Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating | | $1.69 -0.3% | $3.00 ➝ $2.00 | Buy ➝ Neutral | |
LEN Lennar | Target Lowered by | JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating | | $121.90 -4.3% | $97.00 ➝ $92.00 | Neutral | |
LEN Lennar | Reiterated by | Wedbush Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating | | $121.90 -4.3% | $130.00 | Neutral | |
LEN Lennar | Target Raised by | Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating | | $121.90 -4.3% | $98.00 ➝ $106.00 | Sector Perform | |
LEN Lennar | Target Raised by | Evercore ISI Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating | | $121.90 -4.3% | $114.00 ➝ $118.00 | In-Line | |
LEN Lennar | Target Raised by | Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating | | $121.90 -4.3% | $116.00 ➝ $133.00 | Neutral | |
LEN Lennar | Target Raised by | UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating | | $121.90 -4.3% | $146.00 ➝ $161.00 | Buy | |
LEN Lennar | Reiterated by | Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating | | $121.90 -4.3% | | Outperform | |
LEN Lennar | Target Raised by | JMP Securities Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating | | $121.90 -4.3% | $130.00 ➝ $140.00 | Market Perform ➝ Market Outperform | |
LEN Lennar | Downgraded by | Raymond James Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating | | $121.90 -4.3% | | Market Perform ➝ Underperform | |
LINE Lineage | Target Lowered by | Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating | | $40.40 +0.0% | $50.00 ➝ $46.00 | Equal Weight | |
LITE Lumentum | Target Raised by | Rosenblatt Securities Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating | | $164.71 -2.4% | $150.00 ➝ $225.00 | Buy | |
LRCX Lam Research | Target Set by | Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating | | $132.20 +4.2% | $92.00 ➝ $125.00 | Underweight ➝ Equal Weight | |
LSCC Lattice Semiconductor | Target Raised by | Needham & Company LLC Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating | | $74.71 +3.6% | $70.00 ➝ $80.00 | Buy | |
LYFT Lyft | Target Raised by | Benchmark Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating | | $22.63 +0.2% | $20.00 ➝ $26.00 | Buy | |
LYG Lloyds Banking Group | Reiterated by | Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating | | $4.47 +0.3% | | Neutral | |
MBX MBX Biosciences | Reiterated by | Oppenheimer Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating | | $20.00 +100.0% | | Outperform | |
MBX MBX Biosciences | Reiterated by | Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating | | $20.00 +100.0% | | Outperform | |
MBX MBX Biosciences | Reiterated by | Guggenheim Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating | | $20.00 +100.0% | | Buy | |
MCY Mercury General | Reiterated by | Raymond James Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating | | $82.06 +3.2% | $90.00 ➝ $100.00 | Strong-Buy | |
MDB MongoDB | Target Raised by | Canaccord Genuity Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating | | $323.59 +0.0% | $340.00 ➝ $375.00 | Buy | |
MGM MGM Resorts International | Target Lowered by | Mizuho Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating | | $34.55 -3.5% | $58.00 ➝ $56.00 | Outperform | |
MP MP Materials | Target Set by | Daiwa Capital Markets Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating | | $73.19 0.0% | $80.00 | Outperform | |
|
MTD Mettler-Toledo International | Target Raised by | Bank of America Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating | | $1,257.79 -0.6% | $1,260.00 ➝ $1,390.00 | Neutral | |
MU Micron Technology | Target Raised by | Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating | | $164.62 +1.2% | $135.00 ➝ $160.00 | Equal Weight | |
MU Micron Technology | Target Raised by | Stifel Nicolaus Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating | | $164.62 +1.2% | $145.00 ➝ $173.00 | Buy | |
NB NioCorp Developments | Target Raised by | HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating | | $5.99 +2.0% | $4.00 ➝ $8.25 | Buy | |
NBIX Neurocrine Biosciences | Target Raised by | Needham & Company LLC Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating | | $146.62 +1.0% | $161.00 ➝ $170.00 | Buy | |
NBIX Neurocrine Biosciences | Reiterated by | Wedbush Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating | | $146.62 +1.0% | | Outperform | |
NBR Nabors Industries | Reiterated by | Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating | | $38.98 +3.6% | $29.00 ➝ $36.00 | Underweight | |
NEM Newmont | Reiterated by | National Bankshares Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating | | $83.74 +2.5% | | Outperform | |
NRG NRG Energy | Initiated by | Scotiabank Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating | | $171.11 +4.1% | $212.00 | Sector Outperform | |
NTRA Natera | Upgraded by | Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating | | $179.19 -1.1% | | Hold | |
NTRA Natera | Initiated by | Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating | | $179.19 -1.1% | $175.00 | Equal Weight | |
NVDA NVIDIA | Reiterated by | Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating | | $183.61 +3.9% | | Overweight | |
NVDA NVIDIA | Target Set by | DA Davidson Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating | | $183.61 +3.9% | $210.00 | | |
OKLO Oklo | Target Raised by | Wedbush Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating | | $140.08 +3.6% | $80.00 ➝ $150.00 | Outperform | |
ORCL Oracle | Reiterated by | William Blair Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating | | $329.10 +6.6% | | Outperform | |
ORI Old Republic International | Upgraded by | Raymond James Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating | | $40.94 +2.8% | $43.00 ➝ $47.00 | Outperform ➝ Strong-Buy | |
OTLK Oncobiologics | Target Lowered by | Ascendiant Capital Markets Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating | | $0.97 +0.5% | $21.00 ➝ $8.00 | Buy | |
PAYC Paycom Software | Upgraded by | TD Cowen Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating | | $220.08 +1.6% | $246.00 ➝ $258.00 | Hold ➝ Buy | |
PAYX Paychex | Target Lowered by | Stifel Nicolaus Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating | | $130.40 +0.3% | $152.00 ➝ $142.00 | Hold | |
PGR Progressive | Target Lowered by | Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating | | $241.26 -0.4% | $267.00 ➝ $265.00 | Equal Weight | |
PGRE Paramount Group | Downgraded by | Evercore ISI Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating | | $6.54 +0.1% | | Strong-Buy ➝ Hold | |
PGRE Paramount Group | Target Set by | Evercore ISI Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating | | $6.54 +0.1% | $6.60 | Outperform ➝ In-Line | |
PLXS Plexus | Target Set by | Williams Trading Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating | | $143.62 +1.9% | $165.00 | | |
PLXS Plexus | Target Raised by | Benchmark Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating | | $143.62 +1.9% | $160.00 ➝ $165.00 | Buy | |
PPTA Perpetua Resources | Reiterated by | Roth Capital Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating | | $18.86 +3.0% | | Buy | |
PRCH Porch Group | Reiterated by | Oppenheimer Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating | | $18.89 +0.2% | $17.00 ➝ $25.00 | Outperform | |
PRIM Primoris Services | Initiated by | Glj Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating | | $133.22 +3.4% | $160.00 | Buy | |
PSX Phillips 66 | Target Raised by | UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating | | $129.86 +0.1% | $143.00 ➝ $150.00 | Buy | |
QBTS D-Wave Quantum | Target Raised by | B. Riley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating | | $25.65 -4.6% | $22.00 ➝ $33.00 | Buy | |
R Ryder System | Initiated by | Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating | | $185.03 +0.7% | $217.00 | Buy | |
RBLX Roblox | Target Raised by | JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating | | $136.88 +1.3% | $150.00 ➝ $160.00 | Overweight | |
RGEN Repligen | Upgraded by | Evercore ISI Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating | | $125.94 +3.0% | $130.00 ➝ $155.00 | In-Line ➝ Outperform | |
RGTI Rigetti Computing | Target Raised by | B. Riley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating | | $28.37 -0.5% | $19.00 ➝ $35.00 | Buy | |
RJF Raymond James Financial | Reiterated by | Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating | | $175.44 +0.8% | $170.00 ➝ $180.00 | Neutral | |
RNA Avidity Biosciences | Target Lowered by | Evercore ISI Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating | | $42.34 +3.1% | $70.00 ➝ $65.00 | Outperform | |
RNTX Rein Therapeutics | Upgraded by | HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating | | $1.18 -2.5% | | Strong-Buy | |
RNTX Rein Therapeutics | Initiated by | HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating | | $1.18 -2.5% | $10.00 | Buy | |
RVTY Revvity | Target Lowered by | Bank of America Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating | | $86.38 -0.4% | $110.00 ➝ $99.00 | Buy | |
RY Royal Bank Of Canada | Upgraded by | Erste Group Bank Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating | | $148.72 +1.0% | | Hold ➝ Buy | |
RZLT Rezolute | Reiterated by | Guggenheim Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating | | $8.14 +5.7% | $15.00 | Buy | |
SGHC Super Group (SGHC) | Reiterated by | Needham & Company LLC Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating | | $12.92 +9.8% | $15.00 | Buy | |
SGHC Super Group (SGHC) | Target Raised by | JMP Securities Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating | | $12.92 +9.8% | $15.00 ➝ $16.00 | Market Outperform | |
SGHC Super Group (SGHC) | Reiterated by | Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating | | $12.92 +9.8% | | Outperform | |
SHOO Steven Madden | Upgraded by | Piper Sandler Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating | | $33.16 +3.6% | $25.00 ➝ $40.00 | Neutral ➝ Overweight | |
SINT Sintx Technologies | Target Lowered by | Ascendiant Capital Markets Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating | | $4.71 -4.5% | $28.00 ➝ $25.00 | Buy | |
SKIN Beauty Health | Target Raised by | TD Cowen Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating | | $2.28
| $2.00 ➝ $2.50 | Hold | |
SKIN Beauty Health | Reiterated by | Cowen Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating | | $2.28
| | Hold | |
SRPT Sarepta Therapeutics | Upgraded by | BMO Capital Markets Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating | | $18.65 +7.0% | $50.00 | Market Perform ➝ Outperform | |
SSL Sasol | Downgraded by | Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating | | $6.23 -6.3% | | Overweight ➝ Equal Weight | |
STX Seagate Technology | Target Raised by | Cantor Fitzgerald Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating | | $229.33 +3.7% | $175.00 ➝ $280.00 | Overweight | |
|
TER Teradyne | Target Raised by | Susquehanna Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating | | $135.18 +12.8% | $133.00 ➝ $200.00 | Positive | |
TLN Talen Energy | Initiated by | Scotiabank Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating | | $429.72 +1.5% | $418.00 | Sector Perform | |
TOST Toast | Target Set by | Robert W. Baird Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating | | $38.94 -5.3% | $48.00 | | |
TSLA Tesla | Target Raised by | Piper Sandler Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating | | $434.21 +1.9% | $400.00 ➝ $500.00 | Overweight | |
UIS Unisys | Initiated by | Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating | | $4.11 +2.2% | $4.00 | Hold | |
URI United Rentals | Target Raised by | JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating | | $943.48 +0.2% | $1,000.00 ➝ $1,150.00 | Overweight | |
USAU US Gold | Target Raised by | Roth Capital Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating | | $16.33 +2.5% | $19.00 ➝ $20.00 | Buy | |
V Visa | Downgraded by | Erste Group Bank Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating | | $344.28 +0.8% | | Buy ➝ Hold | |
VKTX Viking Therapeutics | Reiterated by | BTIG Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating | | $26.25 +3.3% | $125.00 | Buy | |
VLO Valero Energy | Target Raised by | UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating | | $166.52 +2.4% | $165.00 ➝ $183.00 | Buy | |
VST Vistra | Initiated by | Scotiabank Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating | | $217.88 +3.1% | $256.00 | Sector Outperform | |
VST Vistra | Downgraded by | Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating | | $217.88 +3.1% | | Buy ➝ Hold | |
WAB Wabtec | Initiated by | Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating | | $197.97 +4.9% | $225.00 | Buy | |
WAB Wabtec | Upgraded by | Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating | | $197.97 +4.9% | | Strong-Buy | |
WBD Warner Bros. Discovery | Target Raised by | Sanford C. Bernstein Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating | | $19.64 +1.6% | $13.00 ➝ $16.00 | Market Perform | |
WBD Warner Bros. Discovery | Target Raised by | Moffett Nathanson Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating | | $19.64 +1.6% | $14.00 ➝ $23.00 | Buy | |
WTW Willis Towers Watson Public | Reiterated by | Raymond James Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating | | $338.85 +0.6% | $380.00 ➝ $400.00 | Strong-Buy | |
XEL Xcel Energy | Upgraded by | BMO Capital Markets Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating | | $72.35 +0.3% | $73.00 ➝ $80.00 | Market Perform ➝ Outperform | |
ZETA Zeta Global | Target Raised by | DA Davidson Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating | | $22.11 +2.9% | $25.00 ➝ $27.00 | Buy | |